HCW Biologics Inc. (HCWB)
2025-06-30 | 2025-03-31 | |||
|---|---|---|---|---|
| Revenues | 6,550 | 5,065 | ||
| Cost of revenues | 5,240 | 4,052 | ||
| Net revenues | 1,310 | 1,013 | ||
| Legal expenses, net | - | -1,739,493 | ||
| Research and development | 1,226,824 | 1,478,711 | ||
| Nonoperating loss | - | - | ||
| General and administrative | 2,096,021 | 2,227,597 | ||
| Legal expenses (recoveries), net | 142,542 | - | ||
| Total operating expenses | 3,465,387 | 1,966,815 | ||
| Loss from operations | -3,464,077 | -1,965,802 | ||
| Interest expense | 228,714 | 255,822 | ||
| Other income, net | 16,373 | 24,749 | ||
| Unrealized gain on investment | 1,748,688 | - | ||
| Net loss | -1,927,730 | -2,196,875 | ||
| Equity dividend to investor | 10,153,799 | - | ||
| Net loss attributable to common stockholders | -12,081,529 | -2,196,875 | ||
| Earnings per share, basic | -6.79 | -0.05 | ||
| Earnings per share, diluted | -6.79 | -0.05 | ||
| Weighted average number of shares outstanding, basic | 1,780,113 | 44,675,656 | ||
| Weighted average number of shares outstanding, diluted | 1,780,113 | 44,675,656 | ||